Arthur Wingerter

Mainz, RP, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Predicting GD2 expression across cancer types by the integration of pathway topology and transcriptome data.

Predicting GD2 expression across cancer types by the integration of pathway topology and transcriptome data.

Journal: Frontiers in bioinformatics

Published: September 15, 2025

Claudin 6 is a suitable target for CAR T-cell therapy in atypical teratoid/rhabdoid brain tumors and other pediatric solid tumors.

Claudin 6 is a suitable target for CAR T-cell therapy in atypical teratoid/rhabdoid brain tumors and other pediatric solid tumors.

Journal: Journal for immunotherapy of cancer

Published: September 07, 2025

Ganglioside Profiling Uncovers Distinct Patterns in High-Risk Neuroblastoma.

Ganglioside Profiling Uncovers Distinct Patterns in High-Risk Neuroblastoma.

Journal: International journal of molecular sciences

Published: August 01, 2025

The Chimeric Antigen Receptor T Cell Target Claudin 6 Is a Marker for Early Organ-Specific Epithelial Progenitors and Is Expressed in Some Pediatric Solid Tumor Entities.

The Chimeric Antigen Receptor T Cell Target Claudin 6 Is a Marker for Early Organ-Specific Epithelial Progenitors and Is Expressed in Some Pediatric Solid Tumor Entities.

Journal: Cancers

Published: January 28, 2025

Altered retinal vasculature in childhood cancer survivors: Data from the German CVSS-study.

Altered retinal vasculature in childhood cancer survivors: Data from the German CVSS-study.

Journal: Acta ophthalmologica

Published: November 04, 2024

The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial.

The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial.

Journal: Nature communications

Published: January 19, 2024

Development and Phenotype of Heart Failure in Long-Term Survivors of Childhood Cancer: The CVSS Study.

Development and Phenotype of Heart Failure in Long-Term Survivors of Childhood Cancer: The CVSS Study.

Journal: Journal of the American Heart Association

Published: September 26, 2023

Glucosylceramide Synthase Inhibitors Induce Ceramide Accumulation and Sensitize H3K27 Mutant Diffuse Midline Glioma to Irradiation.

Glucosylceramide Synthase Inhibitors Induce Ceramide Accumulation and Sensitize H3K27 Mutant Diffuse Midline Glioma to Irradiation.

Journal: International journal of molecular sciences

Published: April 22, 2023

Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALL.

Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALL.

Journal: Oncoimmunology

Published: March 06, 2023

GD2 Expression in Medulloblastoma and Neuroblastoma for Personalized Immunotherapy: A Matter of Subtype.

GD2 Expression in Medulloblastoma and Neuroblastoma for Personalized Immunotherapy: A Matter of Subtype.

Journal: Cancers

Published: November 08, 2022

Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1.

Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1.

Journal: Cancers

Published: October 28, 2021

Mortality risk among 5-year survivors of childhood cancer in Germany-Results from the CVSS study (Cardiac and Vascular late Sequelae in long-term Survivors of childhood cancer study).

Mortality risk among 5-year survivors of childhood cancer in Germany-Results from the CVSS study (Cardiac and Vascular late Sequelae in long-term Survivors of childhood cancer study).

Journal: International journal of cancer

Published: March 26, 2021

Showing 1-12 of 30

Last Updated: 09/26/2026